Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro

Chi Ming Wei, Cheol H. Kim, Ali A. Khraibi, Virginia M Miller, John C Jr. Burnett

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The present study determined circulating concentrations of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) in Wistar- Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) and also investigated the vasorelaxing action of ANP and CNP on isolated contracted aorta. We also defined the vasorelaxing action of a novel and newly synthesized 27-amino acid chimera of ANP and CNP termed vasonatrin peptide (VNP), which we compared with ANP and CNP in WKY rats and SHR. Plasma and urinary cyclic GMP and sodium excretion were also investigated. Plasma ANP was increased in SHR in contrast to no change in circulating CNP. Plasma and urinary cyclic GMP and sodium excretion were no different between WKY rats and SHR. In WKY rats maximal relaxations to VNP in aortic rings without endothelium were greater than those to ANP and CNP. In SHR aortic rings the potency of VNP relaxation was preserved, the actions of ANP were enhanced, and the actions of CNP were markedly impaired. In association with these vasorelaxing actions, these data suggest that (1) circulating CNP is not different in SHR and WKY rats, but the aortic relaxing action of CNP is markedly impaired in SHR; (2) endogenous plasma ANP is significantly increased in SHR without associated increases in plasma or urinary cyclic GMP; (3) there is an increase in aortic relaxation to exogenous ANP in SHR; and (4) VNP has a potent endothelium-independent aortic relaxing action in both WKY rats and SHR. These data suggest differential regulation of ANP and CNP and their vascular actions in SHR. These data also suggest that VNP could have an important therapeutic role in hypertension.

Original languageEnglish (US)
Pages (from-to)903-907
Number of pages5
JournalHypertension
Volume23
Issue number6 II
StatePublished - Jun 1994

Fingerprint

C-Type Natriuretic Peptide
Atrial Natriuretic Factor
Inbred SHR Rats
Inbred WKY Rats
Cyclic GMP
Endothelium
In Vitro Techniques
polypeptide C
Sodium
Blood Vessels
Aorta

Keywords

  • antihypertensive agents
  • atrial natriuretic peptide
  • muscle, smooth, vascular
  • peptides
  • rats, inbred SHR
  • rats, inbred WKY

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. / Wei, Chi Ming; Kim, Cheol H.; Khraibi, Ali A.; Miller, Virginia M; Burnett, John C Jr.

In: Hypertension, Vol. 23, No. 6 II, 06.1994, p. 903-907.

Research output: Contribution to journalArticle

@article{76cd000eb8a54002babbbe8280fe0ce8,
title = "Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro",
abstract = "The present study determined circulating concentrations of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) in Wistar- Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) and also investigated the vasorelaxing action of ANP and CNP on isolated contracted aorta. We also defined the vasorelaxing action of a novel and newly synthesized 27-amino acid chimera of ANP and CNP termed vasonatrin peptide (VNP), which we compared with ANP and CNP in WKY rats and SHR. Plasma and urinary cyclic GMP and sodium excretion were also investigated. Plasma ANP was increased in SHR in contrast to no change in circulating CNP. Plasma and urinary cyclic GMP and sodium excretion were no different between WKY rats and SHR. In WKY rats maximal relaxations to VNP in aortic rings without endothelium were greater than those to ANP and CNP. In SHR aortic rings the potency of VNP relaxation was preserved, the actions of ANP were enhanced, and the actions of CNP were markedly impaired. In association with these vasorelaxing actions, these data suggest that (1) circulating CNP is not different in SHR and WKY rats, but the aortic relaxing action of CNP is markedly impaired in SHR; (2) endogenous plasma ANP is significantly increased in SHR without associated increases in plasma or urinary cyclic GMP; (3) there is an increase in aortic relaxation to exogenous ANP in SHR; and (4) VNP has a potent endothelium-independent aortic relaxing action in both WKY rats and SHR. These data suggest differential regulation of ANP and CNP and their vascular actions in SHR. These data also suggest that VNP could have an important therapeutic role in hypertension.",
keywords = "antihypertensive agents, atrial natriuretic peptide, muscle, smooth, vascular, peptides, rats, inbred SHR, rats, inbred WKY",
author = "Wei, {Chi Ming} and Kim, {Cheol H.} and Khraibi, {Ali A.} and Miller, {Virginia M} and Burnett, {John C Jr.}",
year = "1994",
month = "6",
language = "English (US)",
volume = "23",
pages = "903--907",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6 II",

}

TY - JOUR

T1 - Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro

AU - Wei, Chi Ming

AU - Kim, Cheol H.

AU - Khraibi, Ali A.

AU - Miller, Virginia M

AU - Burnett, John C Jr.

PY - 1994/6

Y1 - 1994/6

N2 - The present study determined circulating concentrations of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) in Wistar- Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) and also investigated the vasorelaxing action of ANP and CNP on isolated contracted aorta. We also defined the vasorelaxing action of a novel and newly synthesized 27-amino acid chimera of ANP and CNP termed vasonatrin peptide (VNP), which we compared with ANP and CNP in WKY rats and SHR. Plasma and urinary cyclic GMP and sodium excretion were also investigated. Plasma ANP was increased in SHR in contrast to no change in circulating CNP. Plasma and urinary cyclic GMP and sodium excretion were no different between WKY rats and SHR. In WKY rats maximal relaxations to VNP in aortic rings without endothelium were greater than those to ANP and CNP. In SHR aortic rings the potency of VNP relaxation was preserved, the actions of ANP were enhanced, and the actions of CNP were markedly impaired. In association with these vasorelaxing actions, these data suggest that (1) circulating CNP is not different in SHR and WKY rats, but the aortic relaxing action of CNP is markedly impaired in SHR; (2) endogenous plasma ANP is significantly increased in SHR without associated increases in plasma or urinary cyclic GMP; (3) there is an increase in aortic relaxation to exogenous ANP in SHR; and (4) VNP has a potent endothelium-independent aortic relaxing action in both WKY rats and SHR. These data suggest differential regulation of ANP and CNP and their vascular actions in SHR. These data also suggest that VNP could have an important therapeutic role in hypertension.

AB - The present study determined circulating concentrations of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) in Wistar- Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) and also investigated the vasorelaxing action of ANP and CNP on isolated contracted aorta. We also defined the vasorelaxing action of a novel and newly synthesized 27-amino acid chimera of ANP and CNP termed vasonatrin peptide (VNP), which we compared with ANP and CNP in WKY rats and SHR. Plasma and urinary cyclic GMP and sodium excretion were also investigated. Plasma ANP was increased in SHR in contrast to no change in circulating CNP. Plasma and urinary cyclic GMP and sodium excretion were no different between WKY rats and SHR. In WKY rats maximal relaxations to VNP in aortic rings without endothelium were greater than those to ANP and CNP. In SHR aortic rings the potency of VNP relaxation was preserved, the actions of ANP were enhanced, and the actions of CNP were markedly impaired. In association with these vasorelaxing actions, these data suggest that (1) circulating CNP is not different in SHR and WKY rats, but the aortic relaxing action of CNP is markedly impaired in SHR; (2) endogenous plasma ANP is significantly increased in SHR without associated increases in plasma or urinary cyclic GMP; (3) there is an increase in aortic relaxation to exogenous ANP in SHR; and (4) VNP has a potent endothelium-independent aortic relaxing action in both WKY rats and SHR. These data suggest differential regulation of ANP and CNP and their vascular actions in SHR. These data also suggest that VNP could have an important therapeutic role in hypertension.

KW - antihypertensive agents

KW - atrial natriuretic peptide

KW - muscle, smooth, vascular

KW - peptides

KW - rats, inbred SHR

KW - rats, inbred WKY

UR - http://www.scopus.com/inward/record.url?scp=0028301971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028301971&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 903

EP - 907

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6 II

ER -